Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 | Haematologica
Retreatment of Patients Surviving Cancer-Free 2 or More Years After Initial Treatment of Small Cell Lung Cancer
![nCoup, Inc.: SWOG-nCartes Pilot Collaboration Shows Significant Expected Time Savings for Study Data Entry at SCT Annual Meeting nCoup, Inc.: SWOG-nCartes Pilot Collaboration Shows Significant Expected Time Savings for Study Data Entry at SCT Annual Meeting](https://mma.prnewswire.com/media/1089343/nCoup_Inc_Logo.jpg?p=twitter)
nCoup, Inc.: SWOG-nCartes Pilot Collaboration Shows Significant Expected Time Savings for Study Data Entry at SCT Annual Meeting
![Paxman Limb Cryocompression System to be used in SWOG Cancer Research Network Study Testing for Prevention of Chemotherapy Induced Peripheral Neuropathy Paxman Limb Cryocompression System to be used in SWOG Cancer Research Network Study Testing for Prevention of Chemotherapy Induced Peripheral Neuropathy](https://www.accesswire.com/users/newswire/images/726247/2%20systems%20with%202%20wraps%20-%20new%20copy%203%20(6).jpg)
Paxman Limb Cryocompression System to be used in SWOG Cancer Research Network Study Testing for Prevention of Chemotherapy Induced Peripheral Neuropathy
![Session 1A: Organization of the NCI Clinical Trials System | Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary |The National Academies Press Session 1A: Organization of the NCI Clinical Trials System | Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary |The National Academies Press](https://nap.nationalacademies.org/books/12535/gif/7.gif)
Session 1A: Organization of the NCI Clinical Trials System | Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary |The National Academies Press
![Current Standards and Ongoing Controversies in the Management of Locally Advanced Non-Small Cell Lung Cancer - ScienceDirect Current Standards and Ongoing Controversies in the Management of Locally Advanced Non-Small Cell Lung Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0093775405000849-gr1.gif)
Current Standards and Ongoing Controversies in the Management of Locally Advanced Non-Small Cell Lung Cancer - ScienceDirect
![Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma. - Abstract - Europe PMC Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6788007/bin/bloodBLD2019000719absf1.jpg)
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma. - Abstract - Europe PMC
Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care
The SWOG Difference | We support SWOG - what makes a SWOG cancer clinical trial unique? | By The Hope Foundation | Facebook
![Diagnostics | Free Full-Text | Current Update of Laboratory Molecular Diagnostics Advancement in Management of Colorectal Cancer (CRC) Diagnostics | Free Full-Text | Current Update of Laboratory Molecular Diagnostics Advancement in Management of Colorectal Cancer (CRC)](https://www.mdpi.com/diagnostics/diagnostics-10-00009/article_deploy/html/images/diagnostics-10-00009-g001.png)